Leaflet REDERGIN 0.3mg / ml solution for injection

Product code:
W01423001
Quantity:
50
Indicated for:
cognitive disorders; cerebral circulatory disorders
Route of administration:
injectable
Substance:
codergocrine (alkaloid derivative)
ATC
C04AE01 — Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
Codergocrine is an ergot derivative used for the treatment of cerebral and peripheral circulatory disorders. It works by improving blood flow and reducing vascular resistance, helping to alleviate associated symptoms.

The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, dizziness, and headaches. In rare cases, severe reactions such as vasospasm or allergic reactions may occur. Patients should be informed of these risks before use.

General data about REDERGIN 0.3mg / ml

Substance:
codergocrine
Date of latest medicines list:
01-07-2013
Product code:
W01423001
Concentration:
0.3mg / ml
Pharmaceutical form:
solution for injection
Quantity:
50
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for codergocrine

Concentrations available for codergocrine

  • 0.1%
  • 0.3mg/ml
  • 1mg/ml